Mosquito :: MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR

MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTORâ„¢. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.

Pneumonia :: Patients with pneumonia who received pneumococcal vaccine have lower rate of death, ICU admission

Among patients hospitalized with community-acquired pneumonia, those who had previously received the pneumococcal vaccine had a lower risk of death and admission to the intensive care unit than patients who were not vaccinated, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Cancer :: New guide on palliative care services for people living with advanced cancer

WHO today releases its first guide on planning palliative care services for people living with advanced stages of cancer. The guide, which is based on consultations with more than 70 leading cancer experts in the world, has identified highly effective low-cost public health models to care for terminally ill cancer patients, especially in developing countries.

Brain :: Vanderbilt nets brain gene research center

Neuroscientists at Vanderbilt University are stepping into the national limelight with the establishment of a Silvio O. Conte Center for Neuroscience Research. The new center, funded by a $10 million grant from the National Institute of Mental Health (NIMH), will support interdisciplinary studies aimed at understanding the gene networks that control serotonin systems in the brain.